Vapreotide Acetate

醋酸伐普肽

Report date: 2022/05/17 17:46:20
NME

Base Information

Drug NameVapreotide Acetate
Drug Alias Name伐普肽VapreotidaVapreotidumSanvarDocrised +[9] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSomatostatin receptor 5 agonistsSomatostatin receptor 2 inducers
TargetsSomatostatin receptor 5Somatostatin receptor 2
Therapy Area/IndicationsDiarrheaPostoperative ComplicationsIntraoperative Complications +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDebiopharm Group
China Registration ClassN/A

Develop Information

Active CompaniesDebiopharm Group
Inactive CompaniesDebiovision IncNational Cancer Institute
Active IndicationsDiarrheaCrohn DiseaseEsophageal and Gastric Varices +[5] 
Inactive IndicationsPostoperative ComplicationsIntraoperative ComplicationsHemorrhage +[5] 

Other Information

ATC CodeH01CB04
Related LinksWikipediaDrugBankKEGG